Imaging of gliomas with Cis-4-[18F]fluoro-L-proline

被引:22
作者
Langen, KJ [1 ]
Jarosch, M
Hamacher, K
Mühlensiepen, H
Weber, F
Floeth, F
Pauleit, D
Herzog, H
Coenen, HH
机构
[1] Forschungszentrum Julich, Res Ctr, Inst Med, D-5170 Julich, Germany
[2] Forschungszentrum Julich, Res Ctr, Inst Nucl Chem, D-5170 Julich, Germany
[3] Univ Dusseldorf, Clin Nucl Med, D-4000 Dusseldorf, Germany
[4] Univ Dusseldorf, Clin Neurosurg, D-4000 Dusseldorf, Germany
关键词
cis-4-[F-18]fluoro-L-proline; amino acid transport; F98; glioma; autoradiography; PET;
D O I
10.1016/S0969-8051(03)00121-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Tumor imaging with cis-4-[F-18]fluoro-L-proline (cis-FPro) was compared to that of L-[H-3]proline and L-[H-3]methionine in F98 rat gliomas by dual-tracer autoradiography. All tracers exhibited high accumulation in the tumors but in the normal brain significant uptake was observed for L-[H-3]methionine only. Tumor extent on autoradiograms with L-[H-3]proline and L-[H-3]methionine was identical to that of histological staining while autoradiograms of cis-FPro showed diffuse uptake in the penumbra of some tumors. First PET studies in 7 patients with cerebral gliomas demonstrated accumulation of cis-FPro in tumor areas with enhancement of Gd-DTPA on MR scans. Uptake of cis-FPro in normal brain tissue was negligible. In one patient with a glioblastoma accumulation of cis-FPro was also found in two brain areas without enhancement of Gd-DTPA on MR scans. Control of MRI suggested tumor growth in these areas at further follow up. Our results indicate that in most gliomas increased cis-FPro uptake is restricted to areas with disruption of the BBB which limits its clinical utility. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:67 / 75
页数:9
相关论文
共 23 条
[2]   Whole-body kinetics and dosimetry of cis-4-[18F]fluoro-L-proline [J].
Börner, AR ;
Langen, KJ ;
Herzog, H ;
Hamacher, K ;
Müller-Mattheis, V ;
Schmitz, T ;
Ackermann, R ;
Coenen, HH .
NUCLEAR MEDICINE AND BIOLOGY, 2001, 28 (03) :287-292
[3]  
Hamacher K, 1999, J LABELLED COMPD RAD, V42, P1135
[4]   Target volumes in radiotherapy for high-grade malignant glioma of the brain [J].
Jansen, EPM ;
Dewit, LGH ;
van Herk, M ;
Bartelink, H .
RADIOTHERAPY AND ONCOLOGY, 2000, 56 (02) :151-156
[5]  
Jones HA, 2003, J NUCL MED, V44, P483
[6]   MORPHOLOGICAL CHARACTERIZATION OF NITROSOUREA-INDUCED GLIOMA CELL-LINES AND CLONES [J].
KO, L ;
KOESTNER, A ;
WECHSLER, W .
ACTA NEUROPATHOLOGICA, 1980, 51 (01) :23-31
[7]  
Langen KJ, 1997, J NUCL MED, V38, P517
[8]   Transport of cis- and trans-4-[18F]fluoro-L-proline in F98 glioma cells [J].
Langen, KJ ;
Mühlensiepen, H ;
Schmieder, S ;
Hamacher, K ;
Bröer, S ;
Börner, AR ;
Schneeweiss, FHA ;
Coenen, HH .
NUCLEAR MEDICINE AND BIOLOGY, 2002, 29 (06) :685-692
[9]  
Langen KJ, 2001, J NUCL MED, V42, P752
[10]  
Langen KJ, 1999, FRONT RADIAT THER ON, V33, P9